Compare GMM & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GMM | COSM |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4M | 12.9M |
| IPO Year | 2022 | 2009 |
| Metric | GMM | COSM |
|---|---|---|
| Price | $2.14 | $0.27 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 38.5K | ★ 2.6M |
| Earning Date | 01-09-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.15 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $65,271,815.00 |
| Revenue This Year | N/A | $54.08 |
| Revenue Next Year | N/A | $32.66 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.93 |
| 52 Week Low | $0.06 | $0.16 |
| 52 Week High | $5.79 | $1.32 |
| Indicator | GMM | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 33.16 | 63.07 |
| Support Level | $1.04 | $0.25 |
| Resistance Level | $2.71 | $0.28 |
| Average True Range (ATR) | 0.15 | 0.02 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 10.59 | 98.22 |
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital asset development for the metaverse industry. The Company leverages its proprietary Mofy Lab technology platform, which integrates three-dimensional (3D) reconstruction technology and artificial intelligence (AI) interactive technology, to create high-definition virtual versions of physical world objects, including humans, animals, and scenes. It provides comprehensive technology solutions to support virtual content production for use across movies, television series, animation, advertising, and gaming. The Company operates through Virtual Technology Services, which generates the majority of revenue, and Digital Asset Development and others.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.